JD Health International (BKK:JDHEAL19) Beta: N/A (As of Aug. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:JDHEAL19 JD Health International Inc BKK:JDHEAL19
70 GF Score
Price ฿3.36
GF Value ฿4.41
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is JD Health International Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-08-15), JD Health International's Beta is Not available.

JD Health International  (BKK:JDHEAL19) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)

JD Health International Beta Related Terms

JD Health International Beta Historical Data

* Premium members only.

The historical data trend for JD Health International's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JD Health International Beta Chart

JD Health International Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

JD Health International Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BKK:JDHEAL19
70GF Score
JD Health International Inc BKK:JDHEAL19
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

JD Health International Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Is JD Health International (BKK:JDHEAL19) Overvalued in 2026?

Based on GuruFocus' analysis, JD Health International stock appears to be undervalued. The current stock price of ฿3.36 is trading 23.8% below its estimated GF Value™ of ฿4.41. GuruFocus considers JD Health International to be Modestly Undervalued.

Key valuation signals for BKK:JDHEAL19:

  • Beta: N/A
  • GF Value™: ฿4.41 vs. price of ฿3.36 (23.8% below fair value)
  • GF Score™: 70/100 with 1 warning sign

No single metric tells the full story. See the BKK:JDHEAL19 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

JD Health International Business Description

Address No. 20 Kechuang 11 Street, Block C, Building 2, Jingdong Headquarters, Economic and Technological Development Zone, Daxing District, Beijing, CHN, 101111
JD Health is the largest healthcare e-commerce platform in China in terms of revenue. The company offers pharmaceutical drugs and healthcare products on its platform, both as a marketplace that connects merchants to consumers and as a first-party, or 1P, direct retailer. It also offers online consultation from real life doctors and separately partners with offline pharmacies that can provide location-based 24/7 delivery as part of an omnichannel initiative to complement its core e-commerce business. Its closest competitors are Alibaba Health and Meituan for its e-commerce business. As of Dec. 31, 2024, the platform has over 200 million active annual users and over 70,000 merchants. JD Health is 67.49% owned by its parent company, JD.com.
70GF Score

Get the complete analysis for BKK:JDHEAL19

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿3.36
Price
฿4.41
GF Value